110 likes | 128 Vues
According to Coherent Market Insights,The global sarcoma biopsy market is estimated to be valued at US$ 43,205.8 million in 2019,and is expected to reach a CAGR of 2.8% over the forecast period (2020-2027).
E N D
Coherent Market Insights Market Research and Business Consulting Services https://www.coherentmarketinsights.com/ COVID-19 Impact Tracker
SARCOMA BIOPSY MARKET ANALYSIS Sarcoma Biopsy Market,byProduct Type (Reusable Device and Disposable Devices),by End User (Hospitals, Ambulatory Surgical Centers,andDiagnostic Centers), and by Region (North America,LatinAmerica,Europe, Asia Pacific,MiddleEast, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 – 2027.
The global sarcoma biopsy market was valued at US$ 197.94 million in 2019 and is expected to exhibit a CAGR of 2.8% over the forecast period (2020-2027). Drivers • Increasing prevalence of osteosarcoma is expected to drive growth of the global sarcoma biopsy market. • Osteosarcoma is the most common type of cancer affecting bones, and it mostly occurs in children and young adults. On the basis of cells, osteosarcoma is classified as high-, intermediate- and low-grade. For instance, according to the American Cancer Society, IN January 2020, around 800 to 900 new cases of osteosarcoma are diagnosed in the U.S. each year, with around 50% occurs in children and teenagers. • There are different type of biopsy procedures used to diagnose osteosarcoma such as needle biopsy and surgical biopsy.
Figure 1.Global Sarcoma Biopsy Market Share (%) Analysis,ByProduct Type, 2019
Regional Analysis • North America accounted for the largest market share in the global sarcoma biopsy market, owing to rising healthcare expenditure in the U.S. For instance, according to the Committee for a Responsible Federal Budget, in 2017, the U.S. spent around US $ 3.5 trillion, or 18% of the total GDP, on health expenditures, which is more than twice the average among developed countries. • Furthermore, Asia Pacific is also expected to witness significant growth in the global sarcoma biopsy market, owing to increasing healthcare facilities. For instance, according to the India Brand Equity Foundation, in 2015 around 156,926 sub centers, and 196,312 hospitals are present in India.
Figure 2.Global Sarcoma Biopsy Market Value (US$ Mn) & Y-o-Y Growth (%),2017-2027
Competitive Landscape Key players operating in the global sarcoma biopsy market include C. R. Bard, Inc., Becton, Dickinson and Company,ArgonMedical Devices, InVivo Therapeutics Corporation, Cook Medical Incorporated, UROMED, and Sterylab.
Request Sample Report • Request Customization • Download PDF Brochure • Talk to Analyst Reference: https://www.coherentmarketinsights.com/market-insight/sarcoma-biopsy-market-3819
About Us Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. What we provide: • Customized Market Research Services • Industry Analysis Services • Business Consulting Services • Market Intelligence Services • Long term Engagement Model • Country Specific Analysis
Contact Us Mr. Shah Coherent Market Insights Pvt.Ltd. Address: 1001 4th Ave, #3200 Seattle, WA 98154, U.S. Phone: +1-206-701-6702 Email: sales@coherentmarketinsights.com
Thank You! Kindly follow CMI Social Media Profiles for the latest company updates Facebook Linkedin Twitter https://www.coherentmarketinsights.com/